Skip to main content
Indian Journal of Psychiatry logoLink to Indian Journal of Psychiatry
. 2003 Apr-Jun;45(2):49–56.

Trajectory of Psychopharmacology : The role of the clinician and Industry

David Healy *,*
PMCID: PMC2952147  PMID: 21206834

Abstract

Psychopharmacology emerged with the discovery of chlorpromazine in 1952. This led on to the discovery of other antipsychotics, antidepressants, tranquillisers, psychedelics and other drugs. Traditional histories tell of a liberation of the insane from their asylums. This history neglects the rise and fall of antipsychiatry, and the fact that many more people are both employed in and treated by the mental health industry now than ever before. The small companies who manufactured the first drugs have since become the most profitable corporations on the planet, apparently able to mould academic debate at will and to market psychiatric disorders more effectively than they can make new therapeutic agents.

In our efforts to govern ourselves through psychopharmacology, we have set up a future of cosmetic psychopharmacology. These developments have been largely unscrutinized.

Keywords: Psychopharmacology, antipsychiatry, antidepressants, prescriptions, dependence

Full Text

The Full Text of this article is available as a PDF (460.9 KB).


Articles from Indian Journal of Psychiatry are provided here courtesy of Wolters Kluwer -- Medknow Publications

RESOURCES